The LIAISON PLEX® System is Diasorin’s next-generation, sample-to-answer platform for syndromic molecular testing. Its proprietary Flex® Software allows users to select and pay only for clinically relevant targets they need, with the option to release unprocessed targets on demand. This unique capability to customize results empowers clinicians to follow their diagnostic stewardship guidelines, while saving on operational budget.
Long Description
The LIAISON PLEX® System runs panels that are fully integrated to perform amplification, hybridization, and detection of nucleic acids in just one cartridge. Next generation Flex® Software—now with a fully integrated room temperature consumable, bidirectional LIS, random access, and a touchscreen interface—enables customization for your laboratory's ever-changing testing needs. With Flex Testing, you can customize your results, so you always have the right test for the right patient at the right time. Pay only for the targets you process and result, adapting to dynamic reimbursement guidelines while reducing operational and patient cost burdens. Adapt to guidelines, unique testing algorithms, or the specific needs of patients and providers with the LIAISON PLEX® Respiratory Flex Assay. The LIAISON PLEX® bloodstream infection assays provide the flexibility to only test for clinically relevant targets based on Gram stain of a positive blood culture.
High Resolution Image
Small Image
Large Image
Category Product Showcase